This observation highlights the critical role of developmental TF‐mediated epigenetic reprogramming in cancer and might offer a unique therapeutic opportunity to exploit EN1‐mediated epigenetic vulnerability in PDA. Here, EN1 is linked to Patent ductus arteriosus.